Kim et al. 2015, tested 119 invasive ductal carcinoma samples and proposed ER as a marker of relapse and metastasis to axillary lymph nodes in invasive breast cancer (Kim et al. 2015), while in our limited sample size, we found no correlation between hormone receptors and the status of disease. This evidence concerns the gene ESR1 and invasive breast carcinoma.